{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:34:15Z","timestamp":1778067255243,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/inf.0000000000000823","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T11:45:53Z","timestamp":1435837553000},"page":"1115-1117","source":"Crossref","is-referenced-by-count":12,"title":["Confirmation of Host Genetic Determinants in the CFH Region and Susceptibility to Meningococcal Disease in a Central European Study Sample"],"prefix":"10.1097","volume":"34","author":[{"given":"Ariane","family":"Biebl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Muendlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Kinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kabesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Zenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Elling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Keil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Simma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management.","volume":"13","author":"van Deuren","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R2-22-20210202","first-page":"319","article-title":"Meningitis and meningococcal septicaemia.","volume":"32","author":"Pollard","year":"1998","journal-title":"J R Coll Physicians Lond"},{"key":"R3-22-20210202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccc.2013.03.001","article-title":"Severe meningococcal infection: a review of epidemiology, diagnosis, and management.","volume":"29","author":"Campsall","year":"2013","journal-title":"Crit Care Clin"},{"key":"R4-22-20210202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF00258539","article-title":"Prognostic factors of severe infectious purpura in children.","volume":"11","author":"Leclerc","year":"1985","journal-title":"Intensive Care Med"},{"key":"R5-22-20210202","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(13)70341-4","article-title":"A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R6-22-20210202","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00431-005-1719-7","article-title":"Vaccine strategies of meningococcal disease: results of a 10-year population-based study.","volume":"164","author":"Biebl","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R7-22-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1473-3099(14)70806-0","article-title":"Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.","volume":"14","author":"Bijlsma","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R8-22-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(03)00740-0","article-title":"Host genetic determinants of Neisseria meningitidis infections.","volume":"3","author":"Emonts","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R9-22-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ng.640","article-title":"International Meningococcal Genetics Consortium. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.","volume":"42","author":"Davila","year":"2010","journal-title":"Nat Genet"},{"key":"R10-22-20210202","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1097\/01.CCM.0000100122.57249.5D","article-title":"Role of functional plasminogen-activator-inhibitor-1 4G5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.","volume":"31","author":"Haralambous","year":"2003","journal-title":"Crit Care Med"},{"key":"R11-22-20210202","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(98)08350-0","article-title":"Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group.","volume":"353","author":"Hibberd","year":"1999","journal-title":"Lancet"},{"key":"R12-22-20210202","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s00134-004-2303-8","article-title":"Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin.","volume":"30","author":"Fidler","year":"2004","journal-title":"Intensive Care Med"},{"key":"R13-22-20210202","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/379044","article-title":"Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome.","volume":"188","author":"Garred","year":"2003","journal-title":"J Infect Dis"},{"issue":"suppl 8","key":"R14-22-20210202","doi-asserted-by":"crossref","first-page":"I34","DOI":"10.1016\/j.vaccine.2008.11.059","article-title":"Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.","volume":"26","author":"Kugelberg","year":"2008","journal-title":"Vaccine"},{"key":"R15-22-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4419-5635-4_2","article-title":"The role of complement in AMD.","volume":"703","author":"Zipfel","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"R16-22-20210202","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2013.08.099","article-title":"Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.","volume":"31","author":"Rossi","year":"2013","journal-title":"Vaccine"},{"key":"R17-22-20210202","first-page":"103","article-title":"Predicted strain coverage of a new protein-based meningococcal vaccine in the Czech Republic.","volume":"63","author":"Krizova","year":"2014","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"R18-22-20210202","doi-asserted-by":"crossref","first-page":"e00339","DOI":"10.1128\/mBio.00339-13","article-title":"Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.","volume":"4","author":"Lewis","year":"2013","journal-title":"MBio"},{"key":"R19-22-20210202","doi-asserted-by":"crossref","first-page":"e7374","DOI":"10.1371\/journal.pone.0007374","article-title":"CD14 C-159T and toll-like receptor 4 Asp299Gly polymorphisms in surviving meningococcal disease patients.","volume":"4","author":"Biebl","year":"2009","journal-title":"PLoS One"},{"key":"R20-22-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1399-3038.1994.tb00343.x","article-title":"Apopic diseases in infancy. The German multicentre atopy study (MAS-90).","volume":"5","author":"Bermann","year":"1994","journal-title":"Pediatr Allergy Immunol"},{"key":"R21-22-20210202","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/1471-2105-8-428","article-title":"Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool CubeX.","volume":"8","author":"Gaunt","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"R22-22-20210202","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data.","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R23-22-20210202","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/379378","article-title":"A comparison of bayesian methods for haplotype reconstruction from population genotype data.","volume":"73","author":"Stephens","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R24-22-20210202","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program.","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin Trials"},{"key":"R25-22-20210202","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/pch\/16.8.e61","article-title":"From genes to vaccine: a breakthrough in the prevention of meningococcal group B disease.","volume":"16","author":"Major","year":"2011","journal-title":"Paediatr Child Health"},{"key":"R26-22-20210202","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/BSR20140117","article-title":"New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.","volume":"34","author":"Rodriguez","year":"2014","journal-title":"Biosci Rep"},{"key":"R27-22-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.ajkd.2011.11.027","article-title":"Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.","volume":"59","author":"Ariceta","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R28-22-20210202","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00467-011-1929-3","article-title":"Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.","volume":"26","author":"Bouts","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R29-22-20210202","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaci.2013.11.035","article-title":"Early-life determinants of asthma from birth to age 20 years: a German birth cohort study.","volume":"133","author":"Grabenhenrich","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:07:55Z","timestamp":1620954475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201510000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000823","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}